These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12196911)

  • 1. Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders.
    Hahn MK; Blakely RD
    Pharmacogenomics J; 2002; 2(4):217-35. PubMed ID: 12196911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system.
    Hoffman BJ; Hansson SR; Mezey E; Palkovits M
    Front Neuroendocrinol; 1998 Jul; 19(3):187-231. PubMed ID: 9665836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bakuchiol analogs inhibit monoamine transporters and regulate monoaminergic functions.
    Zhao G; Zang SY; Zheng XW; Zhang XH; Guo LH
    Biochem Pharmacol; 2008 May; 75(9):1835-47. PubMed ID: 18329002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of glial monoamine transporters in the central nervous system].
    Inazu M; Takeda H; Matsumiya T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Aug; 23(4):171-8. PubMed ID: 13677912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of allelic variations in transporters to the phenotype of drug response.
    Kirchheiner J; Gründemann D; Schömig E
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):27-32. PubMed ID: 16785267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.
    Kolhatkar RB; Ghorai SK; George C; Reith ME; Dutta AK
    J Med Chem; 2003 May; 46(11):2205-15. PubMed ID: 12747792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ancestry of neuronal monoamine transporters in the Metazoa.
    Caveney S; Cladman W; Verellen L; Donly C
    J Exp Biol; 2006 Dec; 209(Pt 24):4858-68. PubMed ID: 17142674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine transporters: from genes to behavior.
    Gainetdinov RR; Caron MG
    Annu Rev Pharmacol Toxicol; 2003; 43():261-84. PubMed ID: 12359863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safflower extracts functionally regulate monoamine transporters.
    Zhao G; Zheng XW; Gai Y; Chu WJ; Qin GW; Guo LH
    J Ethnopharmacol; 2009 Jul; 124(1):116-24. PubMed ID: 19527825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
    Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
    J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caulis Sinomenii extracts activate DA/NE transporter and inhibit 5HT transporter.
    Zhao G; Bi C; Qin GW; Guo LH
    Exp Biol Med (Maywood); 2009 Aug; 234(8):976-85. PubMed ID: 19491370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are dopaminergic genes involved in a predisposition to pathological aggression? Hypothesizing the importance of "super normal controls" in psychiatricgenetic research of complex behavioral disorders.
    Chen TJ; Blum K; Mathews D; Fisher L; Schnautz N; Braverman ER; Schoolfield J; Downs BW; Comings DE
    Med Hypotheses; 2005; 65(4):703-7. PubMed ID: 15964153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene polymorphisms and behavior.
    McGuffin P
    Pediatr Blood Cancer; 2007 Jun; 48(7):736-7. PubMed ID: 17311348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of suicidal behavior: candidate association genetic approach.
    Zalsman G; Frisch A; Apter A; Weizman A
    Isr J Psychiatry Relat Sci; 2002; 39(4):252-61. PubMed ID: 12756857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current status of association studies in obsessive-compulsive disorder.
    Hemmings SM; Stein DJ
    Psychiatr Clin North Am; 2006 Jun; 29(2):411-44. PubMed ID: 16650716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of monoamine transporters.
    Glatt CE; Reus VI
    Pharmacogenomics; 2003 Sep; 4(5):583-96. PubMed ID: 12943466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis.
    Lin PY; Tsai G
    Biol Psychiatry; 2004 May; 55(10):1023-30. PubMed ID: 15121487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore design and database searching for selective monoamine neurotransmitter transporter ligands.
    Macdougall IJ; Griffith R
    J Mol Graph Model; 2008 Apr; 26(7):1113-24. PubMed ID: 18023378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics.
    Johnson AD; Wang D; Sadee W
    Pharmacol Ther; 2005 Apr; 106(1):19-38. PubMed ID: 15781120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice.
    Ren-Patterson RF; Cochran LW; Holmes A; Sherrill S; Huang SJ; Tolliver T; Lesch KP; Lu B; Murphy DL
    J Neurosci Res; 2005 Mar; 79(6):756-71. PubMed ID: 15672416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.